Relationship between vancomycin dosage and serum trough vancomycin concentrations in pediatric patients with cystic fibrosis

被引:9
|
作者
Durham, Spencer H. [1 ]
Garza, Kimberly B. [2 ]
Eiland, Lea S. [1 ]
机构
[1] Auburn Univ, Harrison Sch Pharm, Dept Pharm Practice, Auburn, AL 36849 USA
[2] Auburn Univ, Harrison Sch Pharm, Hlth Outcomes Res & Policy, Auburn, AL 36849 USA
关键词
INFECTIOUS-DISEASES SOCIETY; INTENSIVE-CARE-UNIT; STAPHYLOCOCCUS-AUREUS; PHARMACOKINETICS; CHILDREN; AMERICA; ADULTS;
D O I
10.2146/ajhp150605
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The association between vancomycin dosage and serum trough vancomycin concentrations in pediatric patients with cystic fibrosis (CF) was examined. Methods. A retrospective chart review was conducted for pediatric patients with CF who received vancomycin between 2006 and 2012 at a children's hospital. Admission-level data, including vancomycin dosage regimens and corresponding serum trough vancomycin concentrations, were collected. Student's t tests, analysis of variance, and Pearson's correlation coefficients were used to test for associations between vancomycin dosage and trough concentrations. Results. Data from 40 hospital admissions (31 patients) were analyzed. Initial vancomycin dosages ranged from 45 to 100 mg/kg/day (mean +/- S.D. 62.9 +/- 14.5 mg/kg/day), and the mean +/- S.D. serum trough vancomycin concentration was 9.7 +/- 5.1 mg/L. Patients received a mean +/- S.D. of 1.5 +/- 1.1 dosage adjustments. Final dosage regimens ranged from 50 to 120 mg/kg/day (mean +/- S.D., 78.8 +/- 16.0 mg/kg/day), and the mean +/- S.D. trough vancomycin concentration was 13.6 +/- 4.4 mg/L. There was no significant correlation between the initial (r = -0.272, p = 0.090) or final (r = 0.024, p = 0.882) vancomycin dosage and corresponding trough vancomycin concentration. A significant correlation was found between dosage and trough vancomycin concentration in patients age 12 years or older for the initial (r = 0.545, p = 0.003) and final (r = 0.425, p = 0.024) dosages, with no significant correlations found in patients younger than 12 years. Conclusion. A study of hospital admissions involving pediatric patients with CF revealed no significant correlation, when all admissions were considered, between the initial or final vancomycin dosage regimen and the corresponding serum trough vancomycin concentration. Both correlations were significant for the subgroup of admissions representing patients who were at least 12 years old.
引用
收藏
页码:969 / 974
页数:6
相关论文
共 50 条
  • [1] Prediction of Vancomycin Dose for Recommended Trough Concentrations in Pediatric Patients With Cystic Fibrosis
    Amin, Raid W.
    Guttmann, Rodney P.
    Harris, Quianna R.
    Thomas, Janesha W.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (05): : 662 - 665
  • [2] TARGETING HIGHER VANCOMYCIN TROUGH CONCENTRATIONS IN PATIENTS WITH CYSTIC FIBROSIS
    McCrory, B. E.
    McPhail, G. L.
    Szczesniak, R. D.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 316 - 317
  • [3] The Effect of Age and Weight on Vancomycin Serum Trough Concentrations in Pediatric Patients
    Madigan, Theresa
    Sieve, Ronald M.
    Graner, Kevin K.
    Banerjee, Ritu
    PHARMACOTHERAPY, 2013, 33 (12): : 1264 - 1272
  • [4] Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients
    Ploessl, Cady
    White, Christopher
    Manasco, Kalen
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (10) : E244 - E247
  • [5] VANCOMYCIN DOSING IN PEDIATRIC CYSTIC FIBROSIS PATIENTS
    McDade, E. J.
    Hewlett, J. L.
    Moonnumakal, S. P.
    Baker, C. J.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 452 - 452
  • [6] Vancomycin Trough Concentrations in Overweight or Obese Pediatric Patients
    Heble, Daniel E., Jr.
    McPherson, Christopher
    Nelson, Miranda P.
    Hunstad, David A.
    PHARMACOTHERAPY, 2013, 33 (12): : 1273 - 1277
  • [7] Impact of the Implementation of a Vancomycin Protocol on Trough Serum Vancomycin Concentrations in a Pediatric Intensive Care Unit
    Rezende, Raissa Queiroz
    Dias, Cicero Armidio Gomes
    Ricachinevsky, Claudia Pires
    de Lucena Capelari, Joao Paulo
    PEDIATRIC DRUGS, 2021, 23 (03) : 299 - 305
  • [8] Impact of the Implementation of a Vancomycin Protocol on Trough Serum Vancomycin Concentrations in a Pediatric Intensive Care Unit
    Raíssa Queiroz Rezende
    Cícero Armídio Gomes Dias
    Claudia Pires Ricachinevsky
    João Paulo de Lucena Capelari
    Pediatric Drugs, 2021, 23 : 299 - 305
  • [9] The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review
    Tkachuk, Stacey
    Collins, Kyle
    Ensom, Mary H. H.
    PEDIATRIC DRUGS, 2018, 20 (02) : 153 - 164
  • [10] The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review
    Stacey Tkachuk
    Kyle Collins
    Mary H. H. Ensom
    Pediatric Drugs, 2018, 20 : 153 - 164